Normalized bulk streams over the federal record.

The new-to-class prescriber list, straight from Medicare Part D: every physician who entered a therapeutic drug class this Part D year — e.g. new GLP-1 prescribers in PY2024 — with specialty, state, and their year-over-year class-claim delta. The buying moment a pharma field team wants first, filterable by drug_class, specialty, and state. Observational public Part D records, differenced PY2023 → PY2024.

cadence:

yearly (annual Part D release)

price:

$0.05 / page (≤1,000 rows)

A company staffing up, filing by filing: the H-1B LCA and PERM stream from DOL OFLC disclosure files — 268,267 FY2026 rows to date. Each certified case is a role an employer is hiring for, with employer, job title, SOC occupation, offered wage, and worksite. FEIN resolved on 88.9% of 2026 rows, 42,596 rows ticker-mapped to SEC registrants, point-in-time as_published_date vintages, no restatements.

cadence:

quarterly (per OFLC disclosure drop)

price:

$0.05 / page (≤1,000 rows)

Every new federal enforcement action in one flat stream — 165,421 events in the rolling 24-month window: OSHA inspections, EPA ECHO formal actions, and DOL WHD concluded wage cases, resolved to a 3.73M-entity employer graph with match confidence disclosed. Point-in-time discipline: event_date + as_published_date on every row, no restatements.

cadence:

weekly

price:

$0.05 / page (≤1,000 rows)

The full 4.47M-carrier FMCSA census as one analytics-ready table: identity, fleet size, operating status, authority and insurance filings, safety rating, SaferGrade score, and 24-month inspection summaries per USDOT number.

cadence:

daily

price:

$0.05 / page (≤1,000 rows)

9 federal distress markers, one observational composite: 23,207 subjects currently carrying at least one marker — 1,458 of them identifier-verified public-company subjects with ticker and CIK — under point-in-time discipline (event_date + as_published_date, no restatements). WARN notices, Form 5500 participant drops, IRS auto-revocations, SEC going-concern and 8-K distress filings, FMCSA authority revocations, with per-marker counts and dates.

cadence:

rebuilt as legs refresh (daily-monthly sources)

price:

$0.10 / page (≤1,000 rows)

The public-company accumulation signal, straight from SEC Form 4: 430 issuers currently carrying an open-market BUY cluster — several distinct officers, directors, or 10% owners buying the same stock in a trailing 30- or 90-day window (222 of them with 3+ insiders in the 90-day window). Each row is a public company with ticker, CIK, and exchange, the cluster size, and the total dollars purchased, newest-first by the most recent buy. Observational Form 4 filings as filed, never advice.

cadence:

daily (as Form 4s are filed)

price:

$0.05 / page (≤1,000 rows)

The front of the pharma / med-device pipeline, straight from ClinicalTrials.gov: every new interventional, industry-sponsored study as it hits the registry — 112,288 trials across 14,106 sponsor companies, newest-first by posting date. Each row carries the sponsor company, phase, status, conditions, interventions, enrollment, and the US states the trial is sited in — a CRO, trial-software, recruitment, lab, or equity target the day a program stands up.

cadence:

daily (per registry posting)

price:

$0.05 / page (≤1,000 rows)

The funded-growth signal, straight from USAspending: 95,890 federal prime awards across 24,323 recipient companies (63,820 of them $1M+), newest-first by action date. Each row carries the awardee, awarding agency, award amount (with a banded size bucket), NAICS, dates, and UEI — a company that just won federal money, the moment it lands. A teaming, staffing, B2B, or equity target the day the award posts.

cadence:

daily (as awards post)

price:

$0.05 / page (≤1,000 rows)

The R&D / growth signal, straight from USPTO / PatentsView: 30,254 granted-patent assignee companies ranked by grant count in the window (10,867 of them first-time assignees, 1,868 with 10+ grants). Each row carries the organization, grant count, CPC technology areas, grant-date window, inventor count, and a first-time-assignee flag — a company investing in R&D. A tech, pharma, device, IP, or equity target. CC BY 4.0 attribution.

cadence:

semiannual (per PatentsView bulk load)

price:

$0.05 / page (≤1,000 rows)

The small-business growth-capital signal, straight from the SBA 7(a) & 504 FOIA files: 504,412 approved loans (386,611 7(a), 117,801 504), newest-first by approval date. Each row carries the borrower, city/state, program, approval amount (with a banded size bucket), lender/CDC, NAICS, and jobs supported — a business just funded to grow. A lender, equipment, B2B, or equity target the day the approval posts.

cadence:

weekly (per SBA FOIA refresh)

price:

$0.05 / page (≤1,000 rows)

The commercial-launch signal, straight from openFDA Drugs@FDA: 25,450 drug approvals and supplements by sponsor company, newest-first by approval date. Each row carries the sponsor, application number/type, brand names, active ingredients, dosage/route, and marketing status — a drug cleared to market. A pharma-services, agency, or equity target the day the approval posts.

cadence:

weekly (per openFDA refresh)

price:

$0.05 / page (≤1,000 rows)

The device-launch signal, straight from openFDA: 232,324 device clearances and approvals (175,559 510(k), 56,765 PMA), newest-first by decision date. Each row carries the applicant (manufacturer), device and generic name, product code, advisory-committee specialty, pathway, and decision — a device cleared to market. A device, supplier, or equity target the day the decision posts.

cadence:

weekly (per openFDA refresh)

price:

$0.05 / page (≤1,000 rows)

The compliance-gap signal, straight from the FDA Warning Letters index: every firm that received a warning letter, newest-first by issue date. Each row carries the recipient firm, product area (drugs, devices, food, tobacco, dietary supplements…), issuing office, the alleged-violation subject, and the response / close-out clock — a firm carrying an open FDA remediation clock, resolved to the entity graph where matched. A CAPA/remediation, QA-consulting, or equity (headline-risk) target. Observational public records as posted — an alleged violation, never an adjudication.

cadence:

weekly (per FDA index refresh)

price:

$0.05 / page (≤1,000 rows)

The new-to-govcon growth signal, straight from USAspending's File F prime→sub cascade: every federal subaward newest-first by action date, with new_only isolating first-time subawardees — a company's debut in federal work coming up through subcontracts. Each row carries the sub-recipient, prime, agency, amount (banded), NAICS, and date. A govcon BD, teaming, staffing, or equity target the day the subaward posts.

cadence:

weekly (per USAspending refresh)

price:

$0.05 / page (≤1,000 rows)

The set-aside growth signal, straight from the verified veteran-owned vendor roster: SDVOSB / VOSB firms newest-first by most recent award date, with each vendor's VA-specific and total federal award totals (banded), NAICS, and state. A set-aside-eligible vendor with recent traction is a teaming, capture, or equity target. Observational public records as filed.

cadence:

weekly (per USAspending refresh)

price:

$0.05 / page (≤1,000 rows)

The environmental-services target roster, straight from EPA RCRAInfo: the standing hazardous-waste handler universe in handler-id order — facility, city/state, generator status, roles (LQG/SQG/VSQG/transporter/TSDF), and NAICS. A large-quantity generator or TSDF is the whole regulated market an EHS vendor, environmental consultant, or insurer sells into. A bulk roster feed (no per-record registration date).

cadence:

monthly (per RCRAInfo refresh)

price:

$0.05 / page (≤1,000 rows)

The labor-relations moment, straight from the NLRB case system: union representation / election petitions (R cases) newest-first by filing date — employer, case type, region, filing date, unit size, and named union, resolved to the entity graph where matched. category widens to ULP charges. A labor-relations counsel, PEO, benefits-broker, staffing, or equity target. Observational public records AS FILED — a petition is a filing, never an adjudication.

cadence:

weekly (per NLRB refresh)

price:

$0.05 / page (≤1,000 rows)